PT (11.5–13.5 s) | 12.4 (0.7) (n = 22) | 12.2 (0.7) (n = 87) | 0.2 |
aPTT (20.0–31.6 s) | 26.7 (4.1) (n = 22) | 25.4 (4.8) (n = 87) | 0.2 |
dRVVT (29.3–42.8 s) | 37.5 (15) (n = 17) | 34.2 (9.3) (n = 52) | 0.3 |
Fibrinogen (150–400 mg/dl) | 499 (206) (n = 37) | 457 (142) (n = 85) | 0.2 |
Protein C deficiency (70–180%) | 2/19 (10%) | 2/62 (3%) | 0.2 |
Protein S deficiency (65–140%) | 0/19 (0) | 3/62 (5%) | 1.0 |
AT III deficiency (80–120%) | 4/19 (21%) | 6/62 (10%) | 0.2 |
APC resistance (>2.1) | 2/14 (14%) | 5/51 (10%) | 0.6 |
ACA IgG (<10 gpl/ml) | 1/35 (3%) | 1/76 (1%) | 1.0 |
ACA IgA (<10 sdu) | 1/35 (3%) | 3/76 (4%) | 1.0 |
ACA IgM (<10 mpl/ml) | 2/35 (6%) | 1/76 (1%) | 0.2 |
Hyperhomocysteinaemia (5.1–13.9 μmol/l) | 2/18 (11%) | 8/51 (16%) | 1.0 |